´ëÇÑÇǺΰúÇÐȸ ¼¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16 |
|
´ëÇÑÇǺΰúÇÐȸ ¼¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16 ±³À°ÀÏÀÚ : 2022-07-16 ±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ¶óº¥´õ·ë ±³À°ÁÖÁ¦ : ´ëÇÑÇǺΰúÇÐȸ ¼¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼¿ïÁöºÎȸ ´ã´çÀÚ : Á¤ÇýÁ¤ ±³¼ö ¿¬¶ôó : 02-2260-7315 À̸ÞÀÏ : humeong01@nmc.or.kr ±³À°Á¾·ù : ÇǺΰú Âü¼®¿¹»óÀοø : 60¸í Èñ¸ÁÆòÁ¡ : 3Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ ¼¼ºÎ¼ö°·á : 500,000¿ø ºñ°í ´ëÇÑÇǺΰúÇÐȸ ¼¿ïÁöºÎȸ ȸ¿ø ÀÌ¿Ü´Â 50¸¸¿ø ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:05~14:25 Dupilumab vs JAK Inhibitor for atopic dermatitis ¾ÈÁö¿µ(±¹¸³Áß¾ÓÀÇ·á¿ø) ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:25~14:45 Safer use of JAK inhibitor ±è¿ë±æ(¿ï»êÀÇ´ë) ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:45~15:05 Practical treatment approaches of chronic urticaria in Korea À̵¿ÈÆ(¼¿ïÀÇ´ë) Åä·Ð 07-16 ¶óº¥´õ·ë 15:05~15:15 Q&A () ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:15~15:35 Treatment of nail dystrophy and ingrowing nail ¿Àº´È£(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:35~15:55 Finasteride vs dutasteride for androgenetic alopecia ÃÖÁö¿õ(¾ÆÁÖÀÇ´ë) ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:55~16:15 Supportive and adjunctive treatment for hair loss ÃÖÀ±Áø(¿¬¼¼º½ºûÇǺΰú) Åä·Ð 07-16 ¶óº¥´õ·ë 16:15~16:25 Q&A () ÈÞ½Ä 07-16 ¶óº¥´õ·ë 16:25~16:50 () ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 16:50~17:10 Increasing the usefulness of patch test in allergic contact dermatitis °íÁÖ¿¬(ÇѾçÀÇ´ë) ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 17:10~17:30 My experience of hypopigmenting agents including tranexamic acid in clinical practice À¯ÈÁ¤(°í·ÁÀÇ´ë) ±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 17:30~17:50 RF vs HIFU: basic steps for skin rejuvenation Á¤¿î°æ(À¯¾ØÁ¤ÇǺΰú) Åä·Ð 07-16 ¶óº¥´õ·ë 17:50~18:00 Q&A () |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|